Page 49 - Read Online

Almeida et al. Vessel Plus 2021;5:44 https://dx.doi.org/10.20517/2574-1209.2021.66 Page 13 of 14

44. Gou SJ, Xu PC, Chen M, Zhao MH. Epitope analysis of anti-myeloperoxidase antibodies in patients with ANCA-associated vasculitis.
PLoS One 2013;8:e60530. DOI PubMed PMC
45. Renn JH, Yang NP, Chueh CM, Lin CY, Lan TH, Chou P. Bone mass in schizophrenia and normal populations across different
decades of life. BMC Musculoskelet Disord 2009;10:1. DOI PubMed PMC
46. Fussner LA, Hummel AM, Schroeder DR, et al; Rituximab in ANCA-Associated Vasculitis-Immune Tolerance Network Research
Group. Factors determining the clinical utility of serial measurements of antineutrophil cytoplasmic antibodies targeting proteinase 3.
Arthritis Rheumatol 2016;68:1700-10. DOI PubMed PMC
47. Schönermarck U, Lamprecht P, Csernok E, Gross WL. Prevalence and spectrum of rheumatic diseases associated with proteinase 3-
antineutrophil cytoplasmic antibodies (ANCA) and myeloperoxidase-ANCA. Rheumatology (Oxford) 2001;40:178-84. DOI PubMed
48. Mahr A, Katsahian S, Varet H, et al; French Vasculitis Study Group (FVSG) and the European Vasculitis Society (EUVAS).
Revisiting the classification of clinical phenotypes of anti-neutrophil cytoplasmic antibody-associated vasculitis: a cluster analysis.
Ann Rheum Dis 2013;72:1003-10. DOI PubMed
49. Lionaki S, Blyth ER, Hogan SL, et al. Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil
cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum
2012;64:3452-62. DOI PubMed PMC
50. Pepper RJ, Draibe JB, Caplin B, et al; RAVE-Immune Tolerance Network Research Group. Association of serum calprotectin
(S100A8/A9) level with disease relapse in proteinase 3-antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheumatol
2017;69:185-93. DOI PubMed PMC
51. Kessenbrock K, Krumbholz M, Schönermarck U, et al. Netting neutrophils in autoimmune small-vessel vasculitis. Nat Med
2009;15:623-5. DOI PubMed PMC
52. Manojlovic M, Juto A, Jonasdottir A, et al. Microparticles expressing myeloperoxidase as potential biomarkers in anti-neutrophil
cytoplasmic antibody (ANCA)-associated vasculitides (AAV). J Mol Med (Berl) 2020;98:1279-86. DOI PubMed PMC
53. Lange C, Csernok E, Moosig F, Holle JU. Immune stimulatory effects of neutrophil extracellular traps in granulomatosis with
polyangiitis. Clin Exp Rheumatol 2017;35 Suppl 103:33-9. PubMed
54. Barnado A, Crofford LJ, Oates JC. At the bedside: neutrophil extracellular traps (NETs) as targets for biomarkers and therapies in
autoimmune diseases. J Leukoc Biol 2016;99:265-78. DOI PubMed PMC
55. Lieberthal JG, Cuthbertson D, Carette S, et al; Vasculitis Clinical Research Consortium. urinary biomarkers in relapsing antineutrophil
cytoplasmic antibody-associated vasculitis. J Rheumatol 2013;40:674-83. DOI PubMed PMC
56. Tam FW, Sanders JS, George A, et al. Urinary monocyte chemoattractant protein-1 (MCP-1) is a marker of active renal vasculitis.
Nephrol Dial Transplant 2004;19:2761-8. DOI PubMed
57. Ohlsson S, Bakoush O, Tencer J, Torffvit O, Segelmark M. Monocyte chemoattractant protein 1 is a prognostic marker in ANCA-
associated small vessel vasculitis. Mediators Inflamm 2009;2009:584916. DOI PubMed PMC
58. O’Reilly VP, Wong L, Kennedy C, et al. Urinary soluble CD163 in active renal vasculitis. J Am Soc Nephrol 2016;27:2906-16. DOI
PubMed PMC
59. Nagai M, Hirayama K, Ebihara I, Higuchi T, Shimohata H, Kobayashi M. Serum levels of the soluble haemoglobin scavenger receptor
CD163 in MPO-ANCA-associated renal vasculitis. Scand J Rheumatol 2016;45:397-403. DOI PubMed
60. Monach PA, Warner RL, Tomasson G, et al. Serum proteins reflecting inflammation, injury and repair as biomarkers of disease
activity in ANCA-associated vasculitis. Ann Rheum Dis 2013;72:1342-50. DOI PubMed PMC
61. Dallos T, Heiland GR, Strehl J, et al. CCL17/thymus and activation-related chemokine in Churg-Strauss syndrome. Arthritis Rheum
2010;62:3496-503. DOI PubMed
62. Vaglio A, Strehl JD, Manger B, et al. IgG4 immune response in Churg-Strauss syndrome. Ann Rheum Dis 2012;71:390-3. DOI
PubMed
63. Pepper RJ, Hamour S, Chavele KM, et al. Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-
associated vasculitis and glomerulonephritis. Kidney Int 2013;83:1150-8. DOI PubMed PMC
64. Szczeklik W, Sanak M, Mastalerz L, et al. 12-hydroxy-eicosatetraenoic acid (12-HETE): a biomarker of Churg-Strauss syndrome. Clin
Exp Allergy 2012;42:513-22. DOI PubMed
65. Henes FO, Chen Y, Bley TA, et al. Correlation of serum level of high mobility group box 1 with the burden of granulomatous
inflammation in granulomatosis with polyangiitis (Wegener’s). Ann Rheum Dis 2011;70:1926-9. DOI PubMed
66. Brogan PA, Dillon MJ. Endothelial microparticles and the diagnosis of the vasculitides. Intern Med 2004;43:1115-9. DOI PubMed
67. Clarke LA, Hong Y, Eleftheriou D, et al. Endothelial injury and repair in systemic vasculitis of the young. Arthritis Rheum
2010;62:1770-80. DOI PubMed
68. Erdbruegger U, Grossheim M, Hertel B, et al. Diagnostic role of endothelial microparticles in vasculitis. Rheumatology (Oxford)
2008;47:1820-5. DOI PubMed
69. Eleftheriou D, Hong Y, Klein NJ, Brogan PA. Thromboembolic disease in systemic vasculitis is associated with enhanced
microparticle-mediated thrombin generation. J Thromb Haemost 2011;9:1864-7. DOI PubMed
70. Eleftheriou D, Ganesan V, Hong Y, Klein NJ, Brogan PA. Endothelial injury in childhood stroke with cerebral arteriopathy: a cross-
sectional study. Neurology 2012;79:2089-96. DOI PubMed PMC
71. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M. Circulating endothelial cells as markers for ANCA-
associated small-vessel vasculitis. Lancet 2003;361:206-10. DOI PubMed
72. Závada J, Kideryová L, Pytlík R, Hrusková Z, Tesar V. Reduced number of endothelial progenitor cells is predictive of early relapse in
anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatology (Oxford) 2009;48:1197-201. DOI PubMed